Carvedilol
Product Images NDC 50090-5115

6 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-5115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Carvedilol (Image 1)

Structural Formula For Carvedilol (Image 1)
Chemical structure of Carvedilol, showing its molecular arrangement with characteristic rings and side chains. The diagram illustrates atoms and bonds, including an indole group and aromatic phenyl ring with a methoxy substituent, connected through an ether and amine linkage.*
FDA Label Image

Figure 1 (Image 2)

Figure 1 (Image 2)
A line graph depicting mortality percentage over a 21-month period comparing Carvedilol versus placebo. The x-axis represents months while the y-axis shows the percentage of mortality. The graph indicates lower mortality with Carvedilol compared to placebo, with a statistically significant p-value of 0.0014.*
FDA Label Image

Figure 2 (Image 3)

Figure 2 (Image 3)
A forest plot chart depicting hazard ratios for various patient subgroups, including gender (men, women), age (<65, ≥65), race (non-black, black), diabetic status, ischemic status, heart rate, systolic blood pressure (SBP), and spironolactone use. Each subgroup is represented with a point estimate and confidence intervals relative to a hazard ratio baseline of 1.0 on the x-axis.*
FDA Label Image

Figure 3 (Image 4)

Figure 3 (Image 4)
A line graph depicting percent mortality over 24 months comparing Carvedilol and Placebo groups. The x-axis represents time in months, and the y-axis shows percent mortality. The Carvedilol group shows consistently lower mortality than the Placebo group, with a reported P value of 0.03.*
FDA Label Image

Figure 4 (Image 5)

Figure 4 (Image 5)
A forest plot showing hazard ratios with confidence intervals for various subgroups related to medical conditions and treatments, such as age, gender, timing of randomization post-MI, prior intravenous or oral beta-blockers, Killip class, thrombolytic therapy, PTCA, chronic heart failure, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Hazard ratios are plotted along the x-axis ranging from 0.4 to 1.3.*
FDA Label Image

Label Image (Lbl500905115)

Label Image (Lbl500905115)
Carvedilol 12.5 mg film-coated tablets label from A-S Medication Solutions, showing packaging for 60 tablets. The label includes storage instructions to keep at 68 to 77 degrees Fahrenheit and protect from moisture. Additional product identification information such as NDC 50090-5115-0 and lot number 5976-0 is also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.